نتائج البحث - Leonardo Faoro
- يعرض 1 - 19 نتائج من 19
-
1
Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with world health organization grade 2 oligodendro... حسب Jorge S. Reis‐Filho, Leonardo Faoro, Carla Carrilho, Luiz Fernando Bleggi‐Torres, Fernando Schmitt
منشور في 2000Artigo -
2
-
3
-
4
-
5
-
6
-
7
BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamou... حسب John D. Hainsworth, Fang Ting Liang, Jane E. Huang, David A. Karlin, Kenneth Russell, Leonardo Faoro, Christopher G. Azzoli
منشور في 2010Artigo -
8
-
9
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Ph... حسب Halla Nimeiri, Amit M. Oza, Robert J. Morgan, Gregory Friberg, Kristen Kasza, Leonardo Faoro, Ravi Salgia, Walter M. Stadler, Everett E. Vokes, Gini F. Fleming
منشور في 2008Artigo -
10
Craniofaringiomas: achados clínicos, epidemiológicos e anatomopatológicos de 25 casos حسب Luíz Fernando Bleggi Torres, Jorge Sérgio Reis Filho, Mário Rodrigues Montemór Netto, LINEI A. B. DELLÉ, Beatriz Garcia Sluminsky, Leonardo Faoro, А Антонюк, Ricardo Ramina
منشور في 1999Artigo -
11
Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial حسب David R. Spigel, P. Townley, David Waterhouse, Fang Ting Liang, İbrahim Adıgüzel, Jane E. Huang, David A. Karlin, Leonardo Faoro, Frank A. Scappaticci, Mark A. Socinski
منشور في 2011Artigo -
12
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription حسب Rajani Kanteti, Vidya Nallasura, Sivakumar Loganathan, Maria Tretiakova, Todd G. Kroll, Soundararajan Krishnaswamy, Leonardo Faoro, Philip T. Cagle, Aliya N. Husain, Everett E. Vokes, Deborah Lang, Ravi Salgia
منشور في 2009Artigo -
13
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors حسب Niharika B. Mettu, Susanna V. Ulahannan, Johanna C. Bendell, Ignacio Garrido‐Laguna, John H. Strickler, Kathleen N. Moore, Robert Stagg, Ann M. Kapoun, Leonardo Faoro, Sunil Sharma
منشور في 2021Artigo -
14
EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation حسب Leonardo Faoro, Patrick A. Singleton, Gustavo M. Cervantes, Frances E. Lennon, Nicholas W. Choong, Rajani Kanteti, Benjamin D. Ferguson, Aliya N. Husain, Maria Tretiakova, Nithya Ramnath, Everett E. Vokes, Ravi Salgia
منشور في 2010Artigo -
15
MET/PKCß expression correlate with metastasis and inhibition is synergistic in lung cancer حسب Ravi Salgia, Leonardo Faoro, GustavoM Cervantes, Benjamin D. Ferguson, TanguyY Seiwert, Soheil Yala, WickiT Vigneswaran, Maria Westerhoff, М. С. Третьякова, MarkK Ferguson, GlaciL Moura, AliyaN Husain, EverettE Vokes
منشور في 2009Artigo -
16
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma حسب Tanguy Y. Seiwert, Ramasamy Jagadeeswaran, Leonardo Faoro, Varalakshmi Janamanchi, Vidya Nallasura, Mohamed El Dinali, Soheil Yala, Rajani Kanteti, Ezra E.W. Cohen, Mark W. Lingen, Leslie E. Martin, Soundararajan Krishnaswamy, Andres J. Klein–Szanto, James G. Christensen, Everett E. Vokes, Ravi Salgia
منشور في 2009Artigo -
17
The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target حسب Benjamin D. Ferguson, Ren Liu, Cleo E. Rolle, Yi‐Hung Carol Tan, Valery Krasnoperov, Rajani Kanteti, Maria Tretiakova, Gustavo M. Cervantes, Rifat Hasina, Robyn D. Hseu, A. John Iafrate, Theodore Karrison, Mark K. Ferguson, Aliya N. Husain, Leonardo Faoro, Everett E. Vokes, Parkash S. Gill, Ravi Salgia
منشور في 2013Artigo -
18
Activating <i>NOTCH1</i> Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potent... حسب Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick A. Zweidler‐McKay, Diana Bell, William N. William, Bonnie S. Glisson, Michael J. Wick, Ann M. Kapoun, Amita Patnaik, Gail Eckhardt, Pamela N. Münster, Leonardo Faoro, Jakob Dupont, J. Jack Lee, P. Andrew Futreal, Adel K. El‐Naggar, John V. Heymach
منشور في 2017Artigo -
19
Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion حسب Ramasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, Varalakshmi Janamanchi, Alexander C. Mackinnon, Tanguy Y. Seiwert, Sivakumar Loganathan, Rajani Kanteti, Trevor Reichman, Vidya Nallasura, Stuart Schwartz, Leonardo Faoro, Yi‐Ching Wang, Luc Girard, Maria Tretiakova, Salman Ahmed, Osvaldo Zumba, Lioubov Soulii, Vytas P. Bindokas, Livia L. Szeto, Gavin J. Gordon, Raphael Bueno, David J. Sugarbaker, Mark W. Lingen, Martin Sattler, Thomas Krausz, Wickii T. Vigneswaran, Viswanathan Natarajan, John D. Minna, Everett E. Vokes, Mark K. Ferguson, Aliya N. Husain, Ravi Salgia
منشور في 2008Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Cancer
Biology
Cancer research
Pathology
Surgery
Cell biology
Lung cancer
Adverse effect
Chemotherapy
Epidermal growth factor receptor
Gastroenterology
Gene
Genetics
Oncology
Signal transduction
Bevacizumab
Clinical endpoint
Receptor tyrosine kinase
Biochemistry
Carboplatin
Carcinogenesis
Carcinoma
Cisplatin
Ecology
Epidemiology
Erlotinib
Focal adhesion
Glioma